Wednesday, November 30, 2016

$MACK - Steady Fall Even in Light of Upgrade

So I bought in on MACK at $5.00 right as a lot of good news regarding their drug Onivyde was popping up. A week or so later it topped off at around 6.80 and has been decreasing steadily for about a week now to its current ~$5.80. It was just upgraded last night by the vetr crowd from a sell (2) to a strong buy (5) yet it continued to fall today. It's right on the cusp of the limit I wanted to get out at, but I originally intended to long it to ~$10.00 based off of its previous high. Only good news has come out about them in the past few weeks, but I'm just wondering if this can simply be chalked up to the classic pharma volatility or if there's something I'm not hearing about.



Submitted November 30, 2016 at 10:50AM by selfsearched http://ift.tt/2gxMotk

No comments:

Post a Comment